'Aclitaxel 80 mg' presentation slideshows

Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA

Will targeting the VEGF-receptor prove to be any more successful in gastroesophageal adenocarcinoma than did targeting its ligand VEGF?. Charles S. Fuchs, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA. VEGF-Mediated Signaling. PlGF. VEGF-A. VEGF-B. VEGF-C. VEGF-D.

580 views • 44 slides